MEROPENEM

MEROPENEM was reported 32715 times

MEROPENEM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI FACTOR V ANTIBODY 22 0.7857
1 NEONATAL CANDIDA INFECTION 18 0.4186
2 MENINGITIS CANDIDA 23 0.3286
3 PROTOTHECOSIS 27 0.2872
4 GEOTRICHUM INFECTION 60 0.2844
5 INTRACRANIAL INFECTION 25 0.2000
6 FOETAL ANAEMIA 24 0.1832
7 TRICHOSPORON INFECTION 69 0.1704
8 RHINOCEREBRAL MUCORMYCOSIS 52 0.1499
9 HERPES SIMPLEX OESOPHAGITIS 27 0.1452
10 PERINEPHRIC ABSCESS 20 0.1316
11 DISSEMINATED MUCORMYCOSIS 51 0.1294
12 EMPHYSEMATOUS PYELONEPHRITIS 23 0.1257
13 URINARY TRACT CANDIDIASIS 24 0.1257
14 DYSBIOSIS 101 0.1230
15 AEROMONAS INFECTION 23 0.1217
16 ACINETOBACTER INFECTION 124 0.1132
17 SYSTEMIC CANDIDA 280 0.1114
18 FACTOR V INHIBITION 20 0.1031
19 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 19 0.0931
20 SPINAL MUSCULAR ATROPHY 25 0.0926
21 STENOTROPHOMONAS INFECTION 124 0.0914
22 CNS VENTRICULITIS 29 0.0890
23 FUNGAEMIA 139 0.0883
24 CONDUCTIVE DEAFNESS 28 0.0872
25 FUSARIUM INFECTION 60 0.0857
26 SCEDOSPORIUM INFECTION 58 0.0822
27 FUNGAL ENDOCARDITIS 23 0.0764
28 POSITIVE AIRWAY PRESSURE THERAPY 21 0.0719
29 SPLENIC ABSCESS 29 0.0713
30 ENTEROCOCCAL SEPSIS 56 0.0691
31 CANDIDA SEPSIS 62 0.0691
32 ENTEROCOCCAL INFECTION 334 0.0691
33 SYSTEMIC MYCOSIS 80 0.0685
34 CLOSTRIDIUM TEST POSITIVE 146 0.0662
35 HYPHAEMA 34 0.0651
36 FUNGAL SEPSIS 53 0.0638
37 VANCOMYCIN INFUSION REACTION 24 0.0637
38 DISSEMINATED ASPERGILLOSIS 30 0.0636
39 PROCALCITONIN INCREASED 74 0.0630
40 ABDOMINAL COMPARTMENT SYNDROME 40 0.0628
41 INFECTIVE ANEURYSM 31 0.0626
42 THROMBOCYTOPENIA NEONATAL 26 0.0618
43 PSEUDOMEMBRANOUS COLITIS 134 0.0600
44 PATHOGEN RESISTANCE 536 0.0587
45 RESPIRATORY TRACT INFECTION BACTERIAL 29 0.0582
46 PYROGLUTAMIC ACIDOSIS 23 0.0579
47 BRAIN ABSCESS 146 0.0576
48 UREAPLASMA INFECTION 23 0.0564
49 MUCORMYCOSIS 145 0.0557
50 HEPATIC INFARCTION 21 0.0557
51 CARDIAC VALVE VEGETATION 27 0.0556
52 ENTEROCOCCUS TEST POSITIVE 36 0.0556
53 BRONCHOPLEURAL FISTULA 20 0.0532
54 PULMONARY NECROSIS 18 0.0528
55 LINEAR IGA DISEASE 87 0.0523
56 PNEUMOCOCCAL SEPSIS 34 0.0518
57 MEDIASTINITIS 30 0.0517
58 ANAL INFLAMMATION 33 0.0516
59 TUMOUR ASSOCIATED FEVER 21 0.0513
60 CANDIDA TEST POSITIVE 21 0.0502
61 KLEBSIELLA INFECTION 250 0.0494
62 PULMONARY MUCORMYCOSIS 26 0.0492
63 BRONCHOPULMONARY ASPERGILLOSIS 380 0.0490
64 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1356 0.0478
65 KLEBSIELLA BACTERAEMIA 45 0.0474
66 ENTEROCOCCAL BACTERAEMIA 49 0.0462
67 HYPERFERRITINAEMIA 19 0.0441
68 CEREBRAL ASPERGILLOSIS 27 0.0439
69 PNEUMONIA NECROTISING 28 0.0433
70 SARS-COV-2 TEST NEGATIVE 29 0.0430
71 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 35 0.0426
72 MYCOBACTERIUM ABSCESSUS INFECTION 30 0.0420
73 SEPSIS SYNDROME 21 0.0418
74 ASPERGILLUS INFECTION 273 0.0416
75 URINARY TRACT INFECTION FUNGAL 23 0.0401
76 PULMONARY NOCARDIOSIS 33 0.0400
77 MULTIPLE-DRUG RESISTANCE 123 0.0396
78 NOCARDIOSIS 101 0.0395
79 NEUTROPENIC COLITIS 81 0.0391
80 MOTOR NEURONE DISEASE 19 0.0390
81 PNEUMONIA PSEUDOMONAL 58 0.0378
82 TRACHEOBRONCHITIS 29 0.0377
83 PSEUDOMONAS INFECTION 322 0.0375
84 PSEUDOMONAL BACTERAEMIA 32 0.0375
85 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 35 0.0370
86 STRONGYLOIDIASIS 59 0.0365
87 HAEMOPERITONEUM 29 0.0362
88 URINARY TRACT INFECTION ENTEROCOCCAL 33 0.0353
89 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 262 0.0349
90 BACILLUS INFECTION 22 0.0348
91 PNEUMONIA FUNGAL 136 0.0344
92 SEPTIC SHOCK 1472 0.0338
93 DELAYED GRAFT FUNCTION 24 0.0338
94 JARISCH-HERXHEIMER REACTION 24 0.0337
95 EOSINOPHILIC PNEUMONIA ACUTE 29 0.0335
96 HYPOFIBRINOGENAEMIA 33 0.0333
97 DISSEMINATED CRYPTOCOCCOSIS 25 0.0330
98 PSEUDOMONAS TEST POSITIVE 27 0.0330
99 LIVER ABSCESS 107 0.0330
100 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 848 0.0329
101 ANTICONVULSANT DRUG LEVEL DECREASED 46 0.0326
102 VIRAL HAEMORRHAGIC CYSTITIS 23 0.0323
103 DRUG RESISTANCE 830 0.0323
104 CYTOKINE STORM 22 0.0321
105 PSEUDOMONAL SEPSIS 56 0.0319
106 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 68 0.0319
107 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 24 0.0319
108 DEVICE RELATED SEPSIS 63 0.0313
109 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 119 0.0311
110 ENTEROBACTER INFECTION 52 0.0309
111 TOXIC EPIDERMAL NECROLYSIS 456 0.0300
112 RASH MORBILLIFORM 83 0.0299
113 BLOOD FIBRINOGEN DECREASED 34 0.0298
114 CLOSTRIDIUM DIFFICILE COLITIS 316 0.0298
115 HYPERCHLORAEMIA 19 0.0297
116 MENINGITIS BACTERIAL 42 0.0293
117 INFECTION IN AN IMMUNOCOMPROMISED HOST 21 0.0292
118 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 23 0.0292
119 OTOTOXICITY 53 0.0286
120 DIFFERENTIATION SYNDROME 21 0.0286
121 METHAEMOGLOBINAEMIA 66 0.0285
122 HISTIOCYTOSIS HAEMATOPHAGIC 84 0.0283
123 PNEUMONIA KLEBSIELLA 52 0.0283
124 GRAFT VERSUS HOST DISEASE IN LIVER 20 0.0279
125 BACTERIAL SEPSIS 91 0.0279
126 NEPHROGENIC DIABETES INSIPIDUS 32 0.0277
127 CYTOMEGALOVIRUS TEST POSITIVE 49 0.0275
128 ACUTE MYELOID LEUKAEMIA RECURRENT 59 0.0275
129 HYPERLACTACIDAEMIA 73 0.0272
130 CANDIDA INFECTION 459 0.0272
131 LUNG CONSOLIDATION 75 0.0268
132 KLEBSIELLA SEPSIS 30 0.0266
133 PULMONARY CAVITATION 23 0.0264
134 WHITE MATTER LESION 33 0.0261
135 APLASTIC ANAEMIA 136 0.0260
136 SEPTIC EMBOLUS 21 0.0252
137 BRONCHOPULMONARY DYSPLASIA 20 0.0248
138 MEGACOLON 39 0.0248
139 EOSINOPHILIA 435 0.0248
140 FEBRILE INFECTION 29 0.0246
141 RENAL ABSCESS 20 0.0244
142 EOSINOPHILIC PNEUMONIA 77 0.0244
143 HAEMATOLOGICAL INFECTION 59 0.0241
144 ISCHAEMIC CEREBRAL INFARCTION 28 0.0241
145 DISSEMINATED INTRAVASCULAR COAGULATION 339 0.0241
146 ESCHERICHIA BACTERAEMIA 56 0.0238
147 COAGULATION TEST ABNORMAL 18 0.0234
148 VANISHING BILE DUCT SYNDROME 26 0.0233
149 BACTERAEMIA 277 0.0233
150 MIXED LIVER INJURY 70 0.0232
151 HYPOPROTEINAEMIA 44 0.0232
152 NOSOCOMIAL INFECTION 51 0.0231
153 INFECTIOUS PLEURAL EFFUSION 35 0.0230
154 STAPHYLOCOCCAL BACTERAEMIA 99 0.0228
155 SPUTUM INCREASED 49 0.0226
156 SUBCUTANEOUS EMPHYSEMA 22 0.0224
157 THERAPEUTIC PRODUCT CROSS-REACTIVITY 20 0.0224
158 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 132 0.0223
159 GRAFT VERSUS HOST DISEASE IN SKIN 49 0.0222
160 NECROTISING COLITIS 28 0.0221
161 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 31 0.0219
162 HYPOPERFUSION 23 0.0219
163 LISTERIOSIS 24 0.0217
164 HYPERLEUKOCYTOSIS 19 0.0214
165 INFLAMMATORY MARKER INCREASED 105 0.0212
166 PNEUMOCYSTIS JIROVECII INFECTION 25 0.0209
167 ACUTE RESPIRATORY DISTRESS SYNDROME 370 0.0209
168 TYPE IV HYPERSENSITIVITY REACTION 57 0.0208
169 HYPOGONADISM 21 0.0208
170 ENCEPHALITIS VIRAL 25 0.0205
171 HAEMODYNAMIC INSTABILITY 155 0.0203
172 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 24 0.0200
173 CEREBRAL PALSY 19 0.0200
174 PULMONARY SEPSIS 29 0.0199
175 HEPATOSPLENOMEGALY 51 0.0199
176 JOINT CONTRACTURE 21 0.0196
177 DERMATITIS EXFOLIATIVE GENERALISED 68 0.0195
178 BRAIN HERNIATION 58 0.0194
179 PNEUMOMEDIASTINUM 35 0.0193
180 METABOLIC ALKALOSIS 31 0.0193
181 ADENOVIRUS INFECTION 56 0.0193
182 PNEUMONIA BACTERIAL 177 0.0193
183 INFECTION REACTIVATION 22 0.0192
184 HEPATITIS FULMINANT 57 0.0192
185 ENDOCARDITIS 98 0.0191
186 FOLATE DEFICIENCY 22 0.0190
187 CARDIOVASCULAR INSUFFICIENCY 31 0.0190
188 VENOOCCLUSIVE LIVER DISEASE 94 0.0190
189 OLIGURIA 118 0.0190
190 TOXIC ENCEPHALOPATHY 95 0.0187
191 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 144 0.0185
192 CROSS SENSITIVITY REACTION 18 0.0185
193 NECROTISING FASCIITIS 65 0.0184
194 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 49 0.0184
195 HAEMORRHAGIC DISORDER 20 0.0184
196 APLASIA 36 0.0184
197 COAGULATION TIME PROLONGED 28 0.0181
198 CHOLESTATIC LIVER INJURY 40 0.0179
199 NEUTROPENIC SEPSIS 127 0.0178
200 HEPATITIS CHOLESTATIC 107 0.0177
201 HYPOALBUMINAEMIA 138 0.0177
202 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 49 0.0177
203 ASPERGILLOSIS 23 0.0176
204 EXCESSIVE EYE BLINKING 26 0.0176
205 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 58 0.0175
206 ISCHAEMIC HEPATITIS 24 0.0175
207 OBLITERATIVE BRONCHIOLITIS 23 0.0175
208 CYTOMEGALOVIRUS VIRAEMIA 78 0.0175
209 HYPERNATRAEMIA 87 0.0174
210 MECHANICAL VENTILATION 33 0.0174
211 FEBRILE NEUTROPENIA 1149 0.0173
212 RETROPERITONEAL HAEMATOMA 38 0.0172
213 CRYPTOCOCCOSIS 28 0.0172
214 LUNG ABSCESS 36 0.0171
215 H1N1 INFLUENZA 24 0.0171
216 STAPHYLOCOCCUS TEST POSITIVE 36 0.0171
217 PNEUMONIA CYTOMEGALOVIRAL 33 0.0170
218 RASH MACULO-PAPULAR 378 0.0170
219 BRONCHIAL DISORDER 26 0.0167
220 PULMONARY HAEMORRHAGE 130 0.0166
221 AGRANULOCYTOSIS 308 0.0166
222 DIFFUSE ALVEOLAR DAMAGE 19 0.0165
223 STAPHYLOCOCCAL SEPSIS 80 0.0162
224 ENTEROCOLITIS 93 0.0161
225 VASCULAR PSEUDOANEURYSM 28 0.0161
226 INTERVERTEBRAL DISCITIS 30 0.0159
227 SHOCK HAEMORRHAGIC 129 0.0158
228 CYTOMEGALOVIRUS INFECTION REACTIVATION 70 0.0158
229 BICYTOPENIA 31 0.0158
230 PUPILS UNEQUAL 18 0.0157
231 RESPIRATORY FAILURE 1143 0.0157
232 INCREASED BRONCHIAL SECRETION 40 0.0156
233 TUMOUR LYSIS SYNDROME 136 0.0154
234 CYTOKINE RELEASE SYNDROME 310 0.0154
235 ESCHERICHIA INFECTION 126 0.0153
236 HYPERCAPNIA 46 0.0153
237 HYPERBILIRUBINAEMIA 158 0.0152
238 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 76 0.0152
239 HYPERTRANSAMINASAEMIA 106 0.0152
240 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 20 0.0152
241 CAPILLARY LEAK SYNDROME 31 0.0150
242 CLOSTRIDIUM COLITIS 18 0.0148
243 ANURIA 126 0.0146
244 RESPIRATORY ACIDOSIS 57 0.0145
245 RESUSCITATION 24 0.0145
246 CYTOMEGALOVIRUS INFECTION 240 0.0144
247 HEPATIC CYTOLYSIS 183 0.0143
248 COAGULOPATHY 238 0.0143
249 ACUTE RESPIRATORY FAILURE 274 0.0142
250 PANCYTOPENIA 794 0.0142
251 CLOSTRIDIUM DIFFICILE INFECTION 310 0.0142
252 CLOSTRIDIAL INFECTION 48 0.0142
253 PRODUCT DEPOSIT 22 0.0141
254 DRUG ERUPTION 249 0.0140
255 BLOOD CULTURE POSITIVE 42 0.0140
256 TACHYPNOEA 188 0.0138
257 HEPATIC NECROSIS 52 0.0138
258 MULTI-ORGAN FAILURE 238 0.0138
259 HYPERAEMIA 27 0.0137
260 TOXIC SKIN ERUPTION 138 0.0137
261 CYSTITIS HAEMORRHAGIC 55 0.0136
262 RESPIRATORY ALKALOSIS 22 0.0135
263 INTRA-ABDOMINAL HAEMORRHAGE 32 0.0134
264 GRAFT VERSUS HOST DISEASE 96 0.0133
265 SUSPECTED OFF LABEL USE 60 0.0133
266 EMPYEMA 26 0.0131
267 PANCREATITIS NECROTISING 30 0.0130
268 COVID-19 PNEUMONIA 154 0.0130
269 EXFOLIATIVE RASH 34 0.0129
270 ENCEPHALOPATHY 315 0.0128
271 TACHYARRHYTHMIA 32 0.0128
272 SEPSIS 1429 0.0128
273 VENOOCCLUSIVE DISEASE 32 0.0128
274 ENCEPHALITIS 88 0.0127
275 EXTREMITY NECROSIS 22 0.0126
276 CYTOMEGALOVIRUS COLITIS 29 0.0126
277 VASCULAR DEVICE INFECTION 57 0.0126
278 RETROPERITONEAL HAEMORRHAGE 31 0.0126
279 NEPHROPATHY TOXIC 141 0.0125
280 BK VIRUS INFECTION 42 0.0124
281 SHOCK 286 0.0124
282 CHOLESTASIS 237 0.0123
283 DRUG LEVEL DECREASED 124 0.0122
284 ENDOTRACHEAL INTUBATION 34 0.0121
285 BACTERIAL TEST POSITIVE 27 0.0121
286 SYSTEMIC INFECTION 20 0.0121
287 INTESTINAL ISCHAEMIA 66 0.0120
288 BILIRUBIN CONJUGATED INCREASED 28 0.0120
289 DISTRIBUTIVE SHOCK 27 0.0119
290 PNEUMOCYSTIS JIROVECII PNEUMONIA 119 0.0118
291 WOUND DEHISCENCE 40 0.0118
292 CEREBELLAR INFARCTION 20 0.0118
293 ACUTE GRAFT VERSUS HOST DISEASE 54 0.0118
294 TRANSPLANT DYSFUNCTION 21 0.0118
295 LEUKOCYTOSIS 212 0.0117
296 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 63 0.0116
297 CHOLANGITIS 71 0.0114
298 HEPATIC FUNCTION ABNORMAL 427 0.0114
299 MENINGITIS 76 0.0114
300 HYPOXIA 400 0.0113
301 POTENTIATING DRUG INTERACTION 38 0.0113
302 BRAIN OEDEMA 143 0.0113
303 ACUTE LYMPHOCYTIC LEUKAEMIA 32 0.0113
304 ACUTE MYELOID LEUKAEMIA 176 0.0113
305 HEPATORENAL SYNDROME 19 0.0112
306 DRUG-INDUCED LIVER INJURY 353 0.0112
307 NEUROLOGICAL DECOMPENSATION 26 0.0112
308 PYELONEPHRITIS ACUTE 22 0.0112
309 ACIDOSIS 85 0.0111
310 ESCHERICHIA SEPSIS 32 0.0110
311 LUNG INFILTRATION 97 0.0110
312 HYPERAMMONAEMIC ENCEPHALOPATHY 19 0.0109
313 THROMBOTIC MICROANGIOPATHY 106 0.0109
314 BONE MARROW FAILURE 221 0.0109
315 HYDROCEPHALUS 59 0.0108
316 C-REACTIVE PROTEIN INCREASED 392 0.0108
317 HERPES SIMPLEX 70 0.0108
318 CHEST X-RAY ABNORMAL 33 0.0108
319 THROMBOCYTOSIS 39 0.0106
320 SKIN NECROSIS 55 0.0106
321 HEPATOMEGALY 104 0.0106
322 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 580 0.0106
323 ATELECTASIS 102 0.0105
324 PULSELESS ELECTRICAL ACTIVITY 44 0.0105
325 LONG QT SYNDROME 25 0.0104
326 SOFT TISSUE INFECTION 19 0.0104
327 METABOLIC ENCEPHALOPATHY 31 0.0103
328 DEVICE RELATED INFECTION 159 0.0103
329 ACUTE HEPATIC FAILURE 141 0.0103
330 THROMBOCYTOPENIA 1153 0.0103
331 HYPERTRIGLYCERIDAEMIA 60 0.0102
332 GRANULOCYTE COUNT DECREASED 19 0.0102
333 HYPOVOLAEMIC SHOCK 49 0.0102
334 BLOOD ALBUMIN DECREASED 81 0.0102
335 GASTROINTESTINAL OEDEMA 18 0.0102
336 PROTEIN TOTAL DECREASED 38 0.0101
337 CARDIAC FAILURE ACUTE 67 0.0100
338 SERUM FERRITIN INCREASED 53 0.0100
339 DRUG LEVEL INCREASED 166 0.0100
340 BACTERIAL INFECTION 187 0.0100
341 NEUROTOXICITY 175 0.0100
342 STEVENS-JOHNSON SYNDROME 222 0.0100
343 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
344 FAECES PALE 22 0.0099
345 ESCHERICHIA URINARY TRACT INFECTION 42 0.0099
346 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 94 0.0098
347 ELECTROENCEPHALOGRAM ABNORMAL 31 0.0098
348 ELECTROLYTE IMBALANCE 114 0.0098
349 DRUG LEVEL BELOW THERAPEUTIC 54 0.0098
350 PNEUMOTHORAX 155 0.0098
351 PNEUMOPERITONEUM 18 0.0097
352 LOW BIRTH WEIGHT BABY 77 0.0097
353 HYPERPYREXIA 41 0.0097
354 COMA SCALE ABNORMAL 28 0.0097
355 HEPATIC FAILURE 291 0.0096
356 TUBULOINTERSTITIAL NEPHRITIS 180 0.0096
357 EPSTEIN-BARR VIRUS INFECTION 60 0.0096
358 EOSINOPHIL COUNT INCREASED 80 0.0096
359 BLOOD LACTATE DEHYDROGENASE INCREASED 152 0.0096
360 AMYLASE INCREASED 35 0.0095
361 FEBRILE BONE MARROW APLASIA 40 0.0094
362 BRAIN DEATH 29 0.0094
363 TRANSPLANT FAILURE 23 0.0094
364 HYPOPHOSPHATAEMIA 69 0.0093
365 HEPATOTOXICITY 207 0.0093
366 PANCREATITIS CHRONIC 22 0.0093
367 COMPLICATIONS OF TRANSPLANTED KIDNEY 21 0.0093
368 INTRAVENTRICULAR HAEMORRHAGE 23 0.0092
369 MYELOSUPPRESSION 332 0.0092
370 HYPERAMMONAEMIA 46 0.0092
371 DERMATITIS EXFOLIATIVE 46 0.0092
372 CLONUS 25 0.0091
373 LEUKOPENIA 454 0.0091
374 CIRCULATORY COLLAPSE 154 0.0090
375 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 21 0.0090
376 PREMATURE DELIVERY 143 0.0090
377 DERMATITIS BULLOUS 65 0.0090
378 ILEUS PARALYTIC 40 0.0090
379 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0089
380 ORGAN FAILURE 36 0.0089
381 QUADRIPLEGIA 18 0.0087
382 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 19 0.0086
383 NECROSIS 48 0.0086
384 ACUTE KIDNEY INJURY 1317 0.0086
385 DISSEMINATED TUBERCULOSIS 22 0.0086
386 FUNGAL INFECTION 285 0.0085
387 HEPARIN-INDUCED THROMBOCYTOPENIA 42 0.0085
388 JAUNDICE CHOLESTATIC 30 0.0085
389 ORGANISING PNEUMONIA 42 0.0085
390 HEPATITIS TOXIC 22 0.0084
391 FIBRIN D DIMER INCREASED 30 0.0084
392 SUBDURAL HAEMORRHAGE 23 0.0084
393 BLOOD BILIRUBIN INCREASED 227 0.0084
394 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 22 0.0084
395 METABOLIC ACIDOSIS 266 0.0083
396 MUCOSAL INFLAMMATION 216 0.0082
397 CYTOPENIA 101 0.0082
398 RHINOVIRUS INFECTION 32 0.0082
399 ABDOMINAL INFECTION 21 0.0082
400 OTITIS MEDIA 27 0.0082
401 STAPHYLOCOCCAL INFECTION 269 0.0081
402 POLYNEUROPATHY 97 0.0081
403 METABOLIC DISORDER 47 0.0081
404 IMMUNE THROMBOCYTOPENIA 37 0.0081
405 PORTAL VEIN THROMBOSIS 26 0.0080
406 HYPERURICAEMIA 33 0.0080
407 HAEMOLYSIS 62 0.0080
408 PROTHROMBIN TIME PROLONGED 48 0.0080
409 TRANSAMINASES INCREASED 178 0.0080
410 HYPERTHERMIA 61 0.0080
411 LUNG OPACITY 21 0.0080
412 CUTANEOUS VASCULITIS 29 0.0079
413 SERUM SICKNESS 22 0.0079
414 AUTOIMMUNE HAEMOLYTIC ANAEMIA 27 0.0079
415 RESPIRATORY DISTRESS 217 0.0079
416 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 40 0.0079
417 LIVER INJURY 192 0.0078
418 HYPOKALAEMIA 356 0.0077
419 STATUS EPILEPTICUS 87 0.0077
420 TRANSPLANT REJECTION 61 0.0076
421 IMMUNOSUPPRESSION 67 0.0076
422 GENERALISED OEDEMA 94 0.0076
423 UPPER GASTROINTESTINAL HAEMORRHAGE 127 0.0075
424 STREPTOCOCCAL INFECTION 42 0.0075
425 RENAL TUBULAR NECROSIS 74 0.0075
426 FOETAL DEATH 39 0.0075
427 RENAL IMPAIRMENT 630 0.0075
428 RENAL TUBULAR DISORDER 21 0.0075
429 MYCOBACTERIUM AVIUM COMPLEX INFECTION 20 0.0074
430 GUILLAIN-BARRE SYNDROME 36 0.0074
431 CEREBRAL ISCHAEMIA 38 0.0074
432 KIDNEY TRANSPLANT REJECTION 35 0.0073
433 LEUKOENCEPHALOPATHY 27 0.0072
434 BLOOD ALKALINE PHOSPHATASE INCREASED 180 0.0072
435 MALNUTRITION 81 0.0072
436 HYPERSENSITIVITY VASCULITIS 19 0.0072
437 CHOLECYSTITIS ACUTE 41 0.0072
438 CYSTIC FIBROSIS 40 0.0072
439 MACULE 20 0.0072
440 DISEASE COMPLICATION 33 0.0072
441 GASTROINTESTINAL NECROSIS 21 0.0072
442 CACHEXIA 37 0.0072
443 HYPOGAMMAGLOBULINAEMIA 47 0.0071
444 ASCITES 210 0.0071
445 GAMMA-GLUTAMYLTRANSFERASE INCREASED 158 0.0071
446 HEPATITIS ACUTE 46 0.0071
447 NEUTROPENIA 960 0.0071
448 RALES 41 0.0071
449 HEPATOCELLULAR INJURY 100 0.0070
450 OESOPHAGEAL CANDIDIASIS 28 0.0070
451 HAEMORRHAGIC DIATHESIS 25 0.0070
452 HYPOTONIA 70 0.0070
453 AZOTAEMIA 28 0.0070
454 PETECHIAE 73 0.0070
455 CARDIOPULMONARY FAILURE 27 0.0069
456 LARGE INTESTINE PERFORATION 48 0.0069
457 COMPARTMENT SYNDROME 18 0.0069
458 HAEMOTHORAX 20 0.0069
459 ORAL CANDIDIASIS 90 0.0068
460 PNEUMONIA ASPIRATION 170 0.0068
461 CARDIAC ARREST 561 0.0068
462 ALANINE AMINOTRANSFERASE INCREASED 415 0.0068
463 AREFLEXIA 18 0.0067
464 HYPERKALAEMIA 236 0.0067
465 UROSEPSIS 62 0.0067
466 BRONCHOPNEUMONIA 23 0.0067
467 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
468 OXYGEN SATURATION ABNORMAL 19 0.0067
469 BLOOD LACTIC ACID INCREASED 35 0.0066
470 BLOOD UREA INCREASED 111 0.0066
471 PANCREATITIS ACUTE 149 0.0066
472 HAEMORRHAGE INTRACRANIAL 99 0.0066
473 BLOOD PHOSPHORUS INCREASED 18 0.0066
474 ACUTE PULMONARY OEDEMA 37 0.0066
475 NEPHRITIS 22 0.0066
476 ABDOMINAL ABSCESS 29 0.0066
477 CEREBRAL HAEMATOMA 22 0.0065
478 VENTRICULAR HYPOKINESIA 21 0.0065
479 ODYNOPHAGIA 39 0.0065
480 PERITONITIS 135 0.0065
481 PLEURAL EFFUSION 395 0.0065
482 CANDIDIASIS 26 0.0065
483 NEUTROPHIL COUNT DECREASED 264 0.0065
484 SUBCUTANEOUS ABSCESS 31 0.0065
485 PYREXIA 2230 0.0064
486 PROCTALGIA 41 0.0064
487 THYROIDITIS 19 0.0063
488 CARDIAC TAMPONADE 30 0.0063
489 GENERALISED TONIC-CLONIC SEIZURE 104 0.0063
490 PNEUMONIA VIRAL 20 0.0063
491 ABSCESS 100 0.0063
492 THROMBOTIC THROMBOCYTOPENIC PURPURA 22 0.0062
493 STUPOR 20 0.0062
494 DRUG INTERACTION 986 0.0062
495 LACTIC ACIDOSIS 201 0.0062
496 CONCOMITANT DISEASE AGGRAVATED 38 0.0062
497 ELECTROCARDIOGRAM QT PROLONGED 221 0.0061
498 ALTERED STATE OF CONSCIOUSNESS 133 0.0061
499 ASPARTATE AMINOTRANSFERASE INCREASED 326 0.0061
500 DRUG LEVEL ABOVE THERAPEUTIC 28 0.0061
501 PARTIAL SEIZURES 32 0.0061
502 EPILEPSY 186 0.0061
503 DEAFNESS NEUROSENSORY 20 0.0061
504 URINE OUTPUT DECREASED 53 0.0061
505 SINUS TACHYCARDIA 86 0.0061
506 MYOCLONUS 72 0.0060
507 DELIRIUM 209 0.0060
508 LYMPHOPENIA 85 0.0060
509 PREMATURE BABY 180 0.0060
510 BONE MARROW DISORDER 18 0.0060
511 PYELONEPHRITIS 51 0.0059
512 DEMYELINATION 24 0.0059
513 ARTHRITIS BACTERIAL 24 0.0058
514 EXTRAVASATION 24 0.0058
515 SPLENOMEGALY 68 0.0058
516 BLOOD CREATININE INCREASED 379 0.0058
517 EMBOLISM 48 0.0058
518 DEPRESSED LEVEL OF CONSCIOUSNESS 228 0.0058
519 PARADOXICAL DRUG REACTION 21 0.0057
520 HEPATITIS 146 0.0057
521 OESOPHAGITIS 61 0.0056
522 HEPATIC LESION 24 0.0055
523 APLASIA PURE RED CELL 19 0.0055
524 BODY TEMPERATURE INCREASED 112 0.0055
525 BREATH SOUNDS ABNORMAL 27 0.0055
526 DIFFUSE LARGE B-CELL LYMPHOMA 42 0.0054
527 PURPURA 48 0.0054
528 LOWER GASTROINTESTINAL HAEMORRHAGE 40 0.0054
529 THERAPY NON-RESPONDER 243 0.0054
530 VENTRICULAR FIBRILLATION 60 0.0054
531 NEUROLEPTIC MALIGNANT SYNDROME 64 0.0054
532 ILEUS 67 0.0054
533 RENAL FAILURE 715 0.0054
534 PURULENT DISCHARGE 23 0.0054
535 PERICARDIAL EFFUSION 124 0.0054
536 MYOSITIS 48 0.0053
537 LIVER FUNCTION TEST ABNORMAL 155 0.0053
538 PYODERMA GANGRENOSUM 19 0.0053
539 EJECTION FRACTION DECREASED 82 0.0053
540 HYPERVOLAEMIA 26 0.0053
541 PNEUMONITIS 143 0.0052
542 HEPATIC ENCEPHALOPATHY 49 0.0052
543 NEUROLOGICAL SYMPTOM 30 0.0052
544 PLATELET COUNT DECREASED 558 0.0052
545 CARDIOGENIC SHOCK 75 0.0052
546 LUNG INFECTION 81 0.0052
547 FUNGAL SKIN INFECTION 21 0.0052
548 COLITIS ISCHAEMIC 35 0.0052
549 ENTERITIS 33 0.0052
550 BRONCHOSPASM 73 0.0051
551 SUBARACHNOID HAEMORRHAGE 52 0.0051
552 RESPIRATORY DISORDER 151 0.0050
553 POSTOPERATIVE WOUND INFECTION 34 0.0050
554 ANAL ABSCESS 27 0.0050
555 MYOPATHY 43 0.0050
556 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44 0.0050
557 SEROTONIN SYNDROME 95 0.0049
558 HAEMOLYTIC ANAEMIA 44 0.0049
559 SUPRAVENTRICULAR TACHYCARDIA 47 0.0049
560 PERIPHERAL ISCHAEMIA 20 0.0049
561 ANAEMIA 930 0.0049
562 HAEMOPTYSIS 136 0.0049
563 OCULAR ICTERUS 21 0.0048
564 CARDIAC DYSFUNCTION 18 0.0048
565 RESPIRATORY SYNCYTIAL VIRUS INFECTION 42 0.0048
566 WHITE BLOOD CELL COUNT INCREASED 185 0.0048
567 INTERSTITIAL LUNG DISEASE 233 0.0048
568 RHABDOMYOLYSIS 200 0.0048
569 LEFT VENTRICULAR DYSFUNCTION 32 0.0048
570 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29 0.0048
571 HAEMODIALYSIS 40 0.0048
572 GASTRITIS EROSIVE 22 0.0047
573 ABSCESS LIMB 20 0.0047
574 PULMONARY TUBERCULOSIS 20 0.0047
575 PLATELET COUNT INCREASED 61 0.0047
576 DUODENAL ULCER 33 0.0047
577 PNEUMONIA 1510 0.0047
578 DECUBITUS ULCER 38 0.0047
579 LYMPHOCYTE COUNT DECREASED 82 0.0046
580 DERMATITIS ALLERGIC 58 0.0046
581 HYPOCALCAEMIA 87 0.0046
582 TORSADE DE POINTES 36 0.0046
583 ISCHAEMIA 21 0.0046
584 GRANULOCYTOPENIA 26 0.0046
585 VENTRICULAR TACHYCARDIA 75 0.0045
586 MENTAL STATUS CHANGES 125 0.0045
587 CEREBRAL INFARCTION 109 0.0045
588 MYOCARDITIS 51 0.0044
589 UNRESPONSIVE TO STIMULI 114 0.0044
590 DISEASE PROGRESSION 521 0.0044
591 RESPIRATORY RATE INCREASED 39 0.0044
592 HYPOTENSION 880 0.0044
593 JAUNDICE 118 0.0044
594 HYPOMAGNESAEMIA 61 0.0044
595 ADRENAL INSUFFICIENCY 53 0.0044
596 OSTEOMYELITIS 79 0.0044
597 ARTHRITIS INFECTIVE 20 0.0043
598 TACHYCARDIA 382 0.0043
599 CONDITION AGGRAVATED 1295 0.0043
600 HEMIPARESIS 72 0.0042
601 PULMONARY MASS 63 0.0042
602 MELAENA 93 0.0042
603 CHRONIC LYMPHOCYTIC LEUKAEMIA 20 0.0042
604 PULMONARY OEDEMA 187 0.0042
605 LIVER DISORDER 185 0.0042
606 GLOMERULAR FILTRATION RATE DECREASED 51 0.0041
607 STILLBIRTH 20 0.0041
608 HYPONATRAEMIA 232 0.0041
609 PAPULE 29 0.0041
610 APNOEA 32 0.0041
611 RESPIRATORY TRACT INFECTION 107 0.0041
612 ACUTE CORONARY SYNDROME 34 0.0041
613 NEUTROPHIL COUNT INCREASED 42 0.0041
614 BLOOD CREATINE PHOSPHOKINASE INCREASED 118 0.0041
615 RENAL FAILURE ACUTE 173 0.0041
616 ERYTHEMA MULTIFORME 38 0.0041
617 HAEMATOMA 105 0.0040
618 FAILURE TO THRIVE 21 0.0040
619 MENINGITIS ASEPTIC 18 0.0040
620 INTERNATIONAL NORMALISED RATIO INCREASED 114 0.0040
621 GASTROINTESTINAL HAEMORRHAGE 332 0.0040
622 GASTROINTESTINAL TOXICITY 19 0.0040
623 HYPOTHERMIA 40 0.0039
624 INTRACRANIAL PRESSURE INCREASED 22 0.0039
625 TREATMENT FAILURE 326 0.0039
626 ASPIRATION 43 0.0039
627 MOTOR DYSFUNCTION 40 0.0039
628 LIPASE INCREASED 30 0.0039
629 OFF LABEL USE 3390 0.0039
630 PULMONARY CONGESTION 51 0.0039
631 NEUTROPHILIA 22 0.0039
632 FACE OEDEMA 65 0.0039
633 CARDIOTOXICITY 34 0.0038
634 OXYGEN SATURATION DECREASED 213 0.0038
635 BRAIN INJURY 38 0.0038
636 GENERAL PHYSICAL HEALTH DETERIORATION 437 0.0038
637 COLITIS 143 0.0038
638 HYPOVOLAEMIA 22 0.0038
639 LYMPHOEDEMA 26 0.0038
640 INFECTION 544 0.0038
641 HYDRONEPHROSIS 28 0.0037
642 GASTROENTERITIS 54 0.0037
643 VASCULITIS 43 0.0037
644 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
645 INTESTINAL PERFORATION 41 0.0036
646 NERVOUS SYSTEM DISORDER 114 0.0036
647 CARDIAC FAILURE 290 0.0036
648 CHOLECYSTITIS 43 0.0036
649 WHITE BLOOD CELL COUNT DECREASED 387 0.0036
650 HYPERCHLORHYDRIA 21 0.0036
651 ORAL DISORDER 26 0.0035
652 PHLEBITIS 18 0.0035
653 DRUG INEFFECTIVE 4620 0.0035
654 ECCHYMOSIS 24 0.0035
655 HAEMATOCRIT DECREASED 69 0.0035
656 HAEMATURIA 119 0.0035
657 BRADYCARDIA 184 0.0035
658 CEREBRAL HAEMORRHAGE 124 0.0035
659 STRESS CARDIOMYOPATHY 20 0.0034
660 CYANOSIS 54 0.0034
661 HAEMOGLOBIN DECREASED 351 0.0034
662 TROPONIN INCREASED 26 0.0034
663 OEDEMA 185 0.0034
664 PANCREATITIS 180 0.0034
665 ATRIAL FIBRILLATION 331 0.0034
666 CELLULITIS 170 0.0034
667 HYPERGLYCAEMIA 122 0.0033
668 PRODUCT USE IN UNAPPROVED INDICATION 829 0.0033
669 CARDIOMEGALY 41 0.0033
670 MYELODYSPLASTIC SYNDROME 48 0.0033
671 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 34 0.0033
672 CARDIO-RESPIRATORY ARREST 138 0.0033
673 EXPOSURE DURING PREGNANCY 205 0.0033
674 RASH PUSTULAR 24 0.0033
675 BRONCHIECTASIS 22 0.0033
676 RASH ERYTHEMATOUS 156 0.0033
677 PULMONARY TOXICITY 23 0.0032
678 PERIPHERAL SENSORY NEUROPATHY 19 0.0032
679 RESPIRATORY ARREST 89 0.0032
680 SCOLIOSIS 20 0.0032
681 SEIZURE 366 0.0032
682 TRANSFUSION 33 0.0031
683 RIGHT VENTRICULAR FAILURE 22 0.0031
684 COMA 149 0.0031
685 HERPES VIRUS INFECTION 18 0.0031
686 TENDERNESS 32 0.0031
687 PROTEINURIA 58 0.0030
688 FACIAL PARALYSIS 26 0.0030
689 HEPATIC ENZYME INCREASED 207 0.0030
690 LYMPHADENOPATHY 107 0.0030
691 SINUS BRADYCARDIA 29 0.0030
692 FLANK PAIN 28 0.0030
693 FOETAL GROWTH RESTRICTION 18 0.0030
694 ABNORMAL FAECES 24 0.0029
695 HYPERCALCAEMIA 36 0.0029
696 SKIN HYPERPIGMENTATION 25 0.0029
697 RED BLOOD CELL COUNT DECREASED 83 0.0029
698 NEPHROPATHY 27 0.0029
699 MIOSIS 23 0.0029
700 LOWER RESPIRATORY TRACT INFECTION 130 0.0029
701 ANAPHYLACTIC SHOCK 73 0.0028
702 FLUID OVERLOAD 41 0.0028
703 PULMONARY FIBROSIS 54 0.0028
704 SECRETION DISCHARGE 35 0.0028
705 APPENDICITIS 26 0.0028
706 MATERNAL EXPOSURE DURING PREGNANCY 248 0.0028
707 ACCIDENT 33 0.0028
708 ATRIAL FLUTTER 22 0.0028
709 LYMPHOMA 42 0.0027
710 PULMONARY HYPERTENSION 56 0.0027
711 ANAPHYLACTIC REACTION 148 0.0027
712 FOETAL EXPOSURE DURING PREGNANCY 217 0.0027
713 SKIN LESION 73 0.0027
714 MOUTH ULCERATION 55 0.0026
715 MUSCLE ATROPHY 33 0.0026
716 RENAL INJURY 77 0.0026
717 HALLUCINATION, VISUAL 54 0.0026
718 CENTRAL NERVOUS SYSTEM LESION 35 0.0025
719 CONTRAINDICATED PRODUCT ADMINISTERED 77 0.0025
720 INFLAMMATION 131 0.0025
721 DIALYSIS 36 0.0025
722 BLOOD PRESSURE DECREASED 167 0.0025
723 SKIN ULCER 64 0.0025
724 BLOOD POTASSIUM INCREASED 40 0.0025
725 SUBDURAL HAEMATOMA 35 0.0024
726 CARDIOMYOPATHY 36 0.0024
727 LETHARGY 140 0.0024
728 HYPOGLYCAEMIA 118 0.0024
729 IMMUNODEFICIENCY 36 0.0024
730 ORAL HERPES 47 0.0024
731 TOXICITY TO VARIOUS AGENTS 405 0.0024
732 CHROMATURIA 54 0.0024
733 MYASTHENIA GRAVIS 19 0.0024
734 PALLOR 64 0.0023
735 TOOTH INFECTION 31 0.0023
736 CHILLS 275 0.0023
737 ARTERIOSCLEROSIS 22 0.0023
738 HYPERTENSIVE CRISIS 26 0.0023
739 LIVER FUNCTION TEST INCREASED 50 0.0023
740 MITRAL VALVE INCOMPETENCE 26 0.0023
741 HAEMORRHOIDS 44 0.0023
742 DISEASE RECURRENCE 107 0.0022
743 URINARY TRACT INFECTION 381 0.0022
744 RENAL DISORDER 104 0.0022
745 NO THERAPEUTIC RESPONSE 27 0.0022
746 INTRAOCULAR PRESSURE INCREASED 28 0.0022
747 HAEMATEMESIS 54 0.0021
748 LUNG DISORDER 104 0.0021
749 BLISTER 119 0.0021
750 ATAXIA 25 0.0021
751 JOINT DISLOCATION 22 0.0021
752 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 147 0.0021
753 DEAFNESS 54 0.0021
754 ACUTE MYOCARDIAL INFARCTION 60 0.0020
755 CONFUSIONAL STATE 328 0.0020
756 HYPOPHAGIA 51 0.0020
757 PERITONITIS BACTERIAL 20 0.0020
758 PULMONARY EMBOLISM 186 0.0020
759 WHEEZING 116 0.0020
760 RASH MACULAR 68 0.0019
761 HEPATIC STEATOSIS 36 0.0019
762 RASH GENERALISED 50 0.0019
763 SKIN REACTION 27 0.0019
764 NEUROPATHY PERIPHERAL 181 0.0019
765 RASH 816 0.0019
766 MYDRIASIS 24 0.0019
767 DERMATITIS 39 0.0019
768 REBOUND EFFECT 21 0.0019
769 COVID-19 326 0.0019
770 CONVULSION 105 0.0018
771 DYSPHAGIA 173 0.0018
772 DISORIENTATION 72 0.0018
773 APHASIA 54 0.0018
774 BLOOD CALCIUM DECREASED 20 0.0018
775 ABDOMINAL PAIN 413 0.0018
776 DIARRHOEA 1139 0.0018
777 HEPATIC CIRRHOSIS 33 0.0018
778 MUSCLE RIGIDITY 21 0.0018
779 BLOOD SODIUM DECREASED 33 0.0017
780 ARRHYTHMIA 82 0.0017
781 STOMATITIS 105 0.0017
782 THERAPY PARTIAL RESPONDER 27 0.0017
783 PAIN IN JAW 49 0.0017
784 HYPOTHYROIDISM 55 0.0017
785 DEEP VEIN THROMBOSIS 110 0.0017
786 IMPAIRED GASTRIC EMPTYING 23 0.0017
787 PRODUCTIVE COUGH 80 0.0017
788 HALLUCINATION 126 0.0017
789 CONJUNCTIVITIS 31 0.0017
790 PHARYNGITIS 20 0.0016
791 GINGIVAL BLEEDING 22 0.0016
792 GASTRITIS 42 0.0016
793 MALIGNANT NEOPLASM PROGRESSION 161 0.0016
794 FAECES DISCOLOURED 34 0.0016
795 GASTRIC HAEMORRHAGE 18 0.0016
796 BLOOD POTASSIUM DECREASED 47 0.0016
797 NEOPLASM PROGRESSION 54 0.0016
798 RESPIRATORY DEPRESSION 19 0.0015
799 RASH PRURITIC 84 0.0015
800 SKIN EXFOLIATION 130 0.0015
801 GASTRIC ULCER 29 0.0015
802 PERICARDITIS 25 0.0015
803 ERYTHEMA 303 0.0015
804 DYSPNOEA 834 0.0015
805 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
806 PRODUCT PRESCRIBING ISSUE 32 0.0015
807 MUSCLE SPASTICITY 18 0.0015
808 RESTLESSNESS 53 0.0014
809 VOMITING 678 0.0014
810 FULL BLOOD COUNT DECREASED 29 0.0014
811 CHOLELITHIASIS 47 0.0014
812 EPISTAXIS 107 0.0014
813 HAEMATOCHEZIA 78 0.0014
814 HYPERTENSION 296 0.0014
815 INFUSION RELATED REACTION 92 0.0014
816 OEDEMA PERIPHERAL 169 0.0014
817 PRODUCT USE ISSUE 260 0.0014
818 INTENTIONAL PRODUCT USE ISSUE 121 0.0014
819 SKIN DISORDER 46 0.0014
820 END STAGE RENAL DISEASE 25 0.0014
821 DECREASED APPETITE 318 0.0014
822 DYSURIA 50 0.0014
823 PRESCRIBED OVERDOSE 26 0.0013
824 HERPES ZOSTER 77 0.0013
825 DYSARTHRIA 50 0.0013
826 HAEMORRHAGE 137 0.0013
827 POST PROCEDURAL COMPLICATION 25 0.0013
828 VISUAL ACUITY REDUCED 43 0.0013
829 MENTAL DISORDER 56 0.0013
830 GASTROINTESTINAL DISORDER 114 0.0013
831 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
832 PARALYSIS 18 0.0013
833 PULMONARY ARTERIAL HYPERTENSION 18 0.0012
834 ISCHAEMIC STROKE 22 0.0012
835 ABDOMINAL DISTENSION 128 0.0012
836 DEHYDRATION 163 0.0012
837 INTESTINAL OBSTRUCTION 46 0.0012
838 PHOTOSENSITIVITY REACTION 20 0.0012
839 MUSCULAR WEAKNESS 137 0.0012
840 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35 0.0012
841 SEDATION 31 0.0012
842 LOSS OF CONSCIOUSNESS 151 0.0012
843 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
844 OSTEONECROSIS OF JAW 29 0.0012
845 HYPERSENSITIVITY 216 0.0012
846 TREATMENT NONCOMPLIANCE 63 0.0012
847 ORTHOSTATIC HYPOTENSION 20 0.0011
848 AGITATION 84 0.0011
849 URINARY INCONTINENCE 33 0.0011
850 ANGIOEDEMA 49 0.0011
851 DIABETIC KETOACIDOSIS 26 0.0011
852 CARDIOVASCULAR DISORDER 27 0.0011
853 PLASMA CELL MYELOMA 41 0.0010
854 THROMBOSIS 84 0.0010
855 TREMOR 173 0.0010
856 COUGH 291 0.0010
857 IMPAIRED HEALING 34 0.0010
858 PRESYNCOPE 25 0.0010
859 CHRONIC KIDNEY DISEASE 78 0.0010
860 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
861 PRURITUS GENERALISED 22 0.0010
862 SOMNOLENCE 201 0.0010
863 OVERDOSE 213 0.0010
864 ACCIDENTAL OVERDOSE 36 0.0010
865 CONSTIPATION 214 0.0010
866 BRONCHITIS 72 0.0010
867 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
868 CHEST PAIN 176 0.0009
869 BACK PAIN 217 0.0009
870 NAUSEA 739 0.0009
871 LABORATORY TEST ABNORMAL 27 0.0009
872 DYSKINESIA 37 0.0009
873 DYSPNOEA EXERTIONAL 34 0.0009
874 DISTURBANCE IN ATTENTION 48 0.0009
875 RECTAL HAEMORRHAGE 38 0.0009
876 HEART RATE INCREASED 86 0.0009
877 SWELLING FACE 56 0.0009
878 ASTHENIA 320 0.0009
879 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 44 0.0008
880 NIGHT SWEATS 27 0.0008
881 MALAISE 367 0.0008
882 TINNITUS 38 0.0008
883 DRUG INTOLERANCE 79 0.0008
884 DIABETES MELLITUS 62 0.0008
885 VIRAL INFECTION 27 0.0008
886 URINARY RETENTION 27 0.0008
887 SINUSITIS 82 0.0008
888 INFLUENZA 89 0.0008
889 NEPHROLITHIASIS 35 0.0008
890 DEATH 657 0.0008
891 PRURITUS 293 0.0008
892 WEIGHT DECREASED 212 0.0008
893 VERTIGO 46 0.0008
894 CYSTITIS 24 0.0008
895 LIP SWELLING 25 0.0007
896 CHEST DISCOMFORT 76 0.0007
897 SYNCOPE 73 0.0007
898 HYPOAESTHESIA 108 0.0007
899 BLINDNESS 29 0.0007
900 THERAPEUTIC RESPONSE DECREASED 43 0.0007
901 COGNITIVE DISORDER 33 0.0007
902 DIVERTICULITIS 19 0.0007
903 DYSSTASIA 20 0.0007
904 PALPITATIONS 80 0.0007
905 URTICARIA 114 0.0007
906 DYSGEUSIA 49 0.0007
907 MOBILITY DECREASED 47 0.0007
908 HYPOACUSIS 28 0.0006
909 DYSPHONIA 38 0.0006
910 OROPHARYNGEAL PAIN 60 0.0006
911 FEELING COLD 18 0.0006
912 THROAT IRRITATION 29 0.0006
913 PSYCHOTIC DISORDER 19 0.0006
914 DYSPEPSIA 61 0.0006
915 FLUSHING 62 0.0006
916 SWOLLEN TONGUE 19 0.0006
917 ABDOMINAL PAIN UPPER 124 0.0006
918 CARDIAC FAILURE CONGESTIVE 48 0.0006
919 MOVEMENT DISORDER 19 0.0006
920 PARAESTHESIA 93 0.0006
921 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
922 MYALGIA 99 0.0006
923 OSTEONECROSIS 19 0.0006
924 SWELLING 54 0.0006
925 MEDICATION ERROR 32 0.0006
926 SPEECH DISORDER 30 0.0006
927 PERIPHERAL SWELLING 88 0.0006
928 SKIN DISCOLOURATION 26 0.0006
929 VISUAL IMPAIRMENT 69 0.0006
930 EYE PAIN 30 0.0005
931 INJURY 37 0.0005
932 ECZEMA 27 0.0005
933 FLUID RETENTION 26 0.0005
934 RHINORRHOEA 33 0.0005
935 NECK PAIN 28 0.0005
936 INTENTIONAL PRODUCT MISUSE 43 0.0005
937 HYPERHIDROSIS 63 0.0005
938 BONE PAIN 28 0.0005
939 ASTHMA 54 0.0005
940 CEREBROVASCULAR ACCIDENT 80 0.0005
941 FATIGUE 361 0.0005
942 PAIN 281 0.0005
943 ABNORMAL BEHAVIOUR 18 0.0005
944 GASTROOESOPHAGEAL REFLUX DISEASE 36 0.0004
945 FLATULENCE 25 0.0004
946 BALANCE DISORDER 38 0.0004
947 HEADACHE 275 0.0004
948 OSTEOPOROSIS 18 0.0004
949 IRRITABILITY 26 0.0004
950 BLOOD PRESSURE INCREASED 65 0.0004
951 FALL 140 0.0004
952 WEIGHT INCREASED 93 0.0004
953 INFLUENZA LIKE ILLNESS 34 0.0004
954 PAIN IN EXTREMITY 121 0.0004
955 ALOPECIA 80 0.0004
956 CATARACT 24 0.0004
957 COLITIS ULCERATIVE 18 0.0004
958 UNDERDOSE 29 0.0004
959 INSOMNIA 103 0.0004
960 NO ADVERSE EVENT 68 0.0004
961 MUSCULOSKELETAL PAIN 19 0.0004
962 ILL-DEFINED DISORDER 22 0.0004
963 ARTHRALGIA 150 0.0004
964 FEELING HOT 22 0.0004
965 CARDIAC DISORDER 33 0.0004
966 ADVERSE DRUG REACTION 31 0.0003
967 SLEEP DISORDER 24 0.0003
968 DISCOMFORT 20 0.0003
969 CONTUSION 31 0.0003
970 DEPRESSION 73 0.0003
971 VISION BLURRED 44 0.0003
972 MUSCULOSKELETAL STIFFNESS 28 0.0003
973 HOSPITALISATION 49 0.0003
974 GAIT DISTURBANCE 61 0.0003
975 DIZZINESS 157 0.0003
976 ABDOMINAL DISCOMFORT 50 0.0003
977 BLOOD GLUCOSE INCREASED 56 0.0003
978 DRUG WITHDRAWAL SYNDROME 26 0.0003
979 INTENTIONAL OVERDOSE 19 0.0003
980 HOT FLUSH 21 0.0003
981 ANXIETY 76 0.0003
982 MUSCLE SPASMS 49 0.0003
983 MYOCARDIAL INFARCTION 43 0.0002
984 ADVERSE EVENT 22 0.0002
985 SUICIDAL IDEATION 21 0.0002
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
987 JOINT SWELLING 25 0.0002
988 EMOTIONAL DISTRESS 23 0.0002
989 FEELING ABNORMAL 43 0.0002
990 NASOPHARYNGITIS 31 0.0002
991 INCORRECT DOSE ADMINISTERED 35 0.0002
992 DRY SKIN 18 0.0001
993 PRODUCT DOSE OMISSION ISSUE 27 0.0001